Full text is available at the source.
Abstract
Pharmacological inhibition of glycolysis in the ventromedial hypothalamus reduces the anorectic effect of the GLP-1 receptor agonist exendin-4.
- Activation of the GLP-1 receptor in the ventromedial hypothalamus reduces food intake.
- Inhibition of glycolysis leads to the activation of AMP-activated protein kinase (AMPK), which diminishes the appetite-suppressing effect of exendin-4.
- Regulation of food intake by GLP-1 receptor activation is associated with mammalian target of rapamycin (mTOR) signaling.
- Exendin-4 activates mTOR signaling in both the ventromedial hypothalamus and CHO-K1 cells.
- Knockdown of the ventromedial hypothalamus does not affect overall energy balance in mice on different diets.
Simplified